Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07520383 · ClinicalTrials.gov registry record · Phase 1
Nanopulse Laser Therapy
A Phase 1 study, sponsored by The University of Texas Medical Branch, Galveston.
- Not yet
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT07520383: Clinical Trial Phase 1 study, sponsored by The University of Texas Medical Branch, Galveston.
NCT07520383 is a Phase 1 study that has not yet begun recruiting, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 30 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07520383, a Phase 1 study, has not yet begun recruiting, sponsored by The University of Texas Medical Branch, Galveston.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of a novel noninvasive therapy, Nanopulse Laser Therapy (NPLT), to improve recovery following traumatic brain injury (TBI).
Primary Outcome
Feasibility will be assessed by the successful administration of NPLT acutely following moderate to severe traumatic brain injury, including protocol adherence and completion of the intervention.
Interventions
- DEVICE Nano-Pulsed Laser Therapy (NPLT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-05 |
| Est. Completion | 2027-05 |
| Phase | Phase 1 |
What is known before NCT07520383 opens enrollment
NCT07520383 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 1 intervention - of which Nano-Pulsed Laser Therapy (NPLT) is the first listed.
NCT07520383 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07520383 about?
NCT07520383 is a clinical study titled "Nanopulse Laser Therapy". The purpose of this study is to evaluate the safety and effectiveness of a novel noninvasive therapy, Nanopulse Laser Therapy (NPLT), to improve recovery following traumatic brain injury (TBI).
What is the current status of trial NCT07520383?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2026-05. Estimated completion is 2027-05.
What interventions are being tested in trial NCT07520383?
The interventions under investigation include: Nano-Pulsed Laser Therapy (NPLT) (DEVICE).
Who is sponsoring clinical trial NCT07520383?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07520383's enrollment target sits among peer trials
30 1332nd of 2000 higher than 561 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia